Nasser K Altorki Selected Research

Nasser K Altorki Research Topics

Disease

67	Neoplasms (Cancer) 02/2024 - 09/2002
32	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 01/2004
21	Lung Neoplasms (Lung Cancer) 01/2024 - 03/2004
20	Esophageal Neoplasms (Esophageal Cancer) 11/2023 - 08/2006
15	Neoplasm Metastasis (Metastasis) 01/2019 - 03/2008
10	Carcinoma (Carcinomatosis) 06/2016 - 04/2003
8	Adenocarcinoma 01/2019 - 10/2008
6	Testicular Neoplasms (Testicular Cancer) 09/2013 - 03/2004
5	Breast Neoplasms (Breast Cancer) 01/2024 - 06/2009
4	Adenocarcinoma of Lung 01/2022 - 06/2016
4	Thymoma (Thymic Carcinoma) 10/2019 - 04/2009
3	Inflammation (Inflammations) 01/2021 - 12/2015
2	Anastomotic Leak 04/2023 - 10/2005
2	Pulmonary Embolism 01/2021 - 07/2012
2	Chronic Obstructive Pulmonary Disease (COPD) 04/2016 - 04/2016
2	Hemorrhage 12/2014 - 09/2013
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2009 - 12/2008
2	Mediastinal Cyst 04/2009 - 06/2003
1	Leukemia 01/2024
1	Microsatellite Instability 11/2021
1	Hepatitis 01/2021
1	Pancreatitis 01/2021
1	Fatigue 01/2021
1	Stroke (Strokes) 01/2021
1	Infections 01/2019
1	Thymus Neoplasms (Thymus Neoplasm) 07/2017
1	Intraoperative Complications 07/2017

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2024 - 09/2002
8	AntigensIBA 01/2019 - 09/2002
5	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 10/2011
5	Biomarkers (Surrogate Marker)IBA 10/2023 - 02/2009
5	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2008 - 01/2003
4	ErbB Receptors (EGF Receptor)IBA 01/2023 - 07/2005
4	Cancer VaccinesIBA 06/2009 - 03/2004
3	durvalumabIBA 01/2024 - 01/2021
3	LigandsIBA 01/2023 - 01/2015
3	Immune Checkpoint InhibitorsIBA 02/2022 - 12/2018
3	Celecoxib (Celebrex)FDA Link 06/2011 - 06/2005
3	VaccinesIBA 02/2010 - 03/2004
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2024 - 06/2023
2	Temozolomide (Temodar)FDA LinkGeneric 01/2024 - 06/2023
2	Alkylating AgentsIBA 01/2024 - 06/2023
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2024 - 06/2023
2	talazoparibIBA 01/2024 - 06/2023
2	Drug CombinationsIBA 01/2024 - 06/2023
2	Dinoprostone (PGE2)FDA Link 01/2023 - 09/2008
2	LipidsIBA 01/2023 - 09/2008
2	RNA IsoformsIBA 01/2023 - 01/2015
2	ProteomeIBA 01/2023 - 02/2009
2	NucleotidesIBA 11/2021 - 02/2010
2	SolutionsIBA 11/2021 - 09/2004
2	Cell-Free Nucleic AcidsIBA 11/2021 - 01/2020
2	CollagenIBA 01/2017 - 08/2014
2	Peptide Hydrolases (Proteases)FDA Link 01/2017 - 12/2015
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2016 - 04/2003
2	Messenger RNA (mRNA)IBA 06/2016 - 06/2009
2	Thrombospondin 1IBA 12/2015 - 01/2015
2	MicroRNAs (MicroRNA)IBA 11/2015 - 10/2009
2	RNA (Ribonucleic Acid)IBA 02/2015 - 01/2015
2	Protein Isoforms (Isoforms)IBA 08/2014 - 04/2004
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 06/2011 - 09/2008
2	taxaneIBA 06/2011 - 06/2005
2	Peptides (Polypeptides)IBA 02/2010 - 09/2002
2	Recombinant ProteinsIBA 10/2009 - 03/2004
2	ProstaglandinsIBA 09/2008 - 06/2005
2	SmokeIBA 07/2005 - 01/2005
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 06/2005 - 04/2004
2	EpitopesIBA 07/2003 - 09/2002
1	amsonic acid (DAS)IBA 01/2024
1	Tissue Inhibitor of Metalloproteinase-1IBA 10/2023
1	CytokinesIBA 10/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023
1	Programmed Cell Death 1 ReceptorIBA 01/2023
1	Aurora KinasesIBA 01/2022
1	milbemycin oxime (Interceptor)IBA 01/2022
1	Circulating Tumor DNAIBA 11/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	Calcibiotic Root Canal SealerIBA 01/2018
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 01/2017
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2017
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017
1	TensinsIBA 01/2017
1	Small Interfering RNA (siRNA)IBA 06/2016

Therapy/Procedure

29	Therapeutics 02/2024 - 05/2005
14	Esophagectomy 04/2023 - 04/2003
9	Neoadjuvant Therapy 01/2023 - 08/2006
9	Thoracotomy 04/2016 - 06/2003
8	Radiotherapy 02/2024 - 02/2010
8	Drug Therapy (Chemotherapy) 04/2016 - 01/2004
7	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 12/2010
5	Segmental Mastectomy (Lumpectomy) 01/2019 - 07/2004
3	Induction Chemotherapy 10/2019 - 08/2007
3	Pneumonectomy (Lung Volume Reduction) 08/2013 - 12/2006
2	Minimally Invasive Surgical Procedures 08/2022 - 12/2011
2	Thymectomy 11/2017 - 07/2017
1	Immunotherapy 02/2024
1	Operative Time 07/2017
1	Length of Stay 01/2017
1	Prostatectomy (Retropubic Prostatectomy) 01/2017